Xianmin Zeng
Buck Institute, Novato, CA, USA
Biography
Dr. Xianmin Zeng received her PhD in Molecular Biology from the Technical University of Denmark in 2000 and had her postdoctoral training at the NIH. She joined the faculty of the Buck Institute Research on Aging in 2005 where she builds the Institute’s Stem Cell Program, and is current Professor at the Buck Institute. Dr. Zeng is a recipient of several major funding including a translational grant to develop clinically grade dopaminergic neurons from pluripotent stem cells for Parkinson’s disease from California Institute for Regenerative Medicine (https://www.cirm.ca.gov/our-progress/people/xianmin-zeng), and an iPSC-based toxicity screen grant from the NIH. She is also the Founder and Chief Executive Officer of XCell Science Inc, a biotech company dedicated to providing reagents and services in neural space, and NxCell Inc, an iPSC-based therapy company.
Abstract
Abstract : Making multiple therapeutic cell products from a cGMP-compliant iPSC line